Dummy Dose Sample Collection in Clinical Trials: How Sponsors can make Dummy Dose Collection Smarter
Blog post by Clinical Supply Consulting experts
blog
Clinical Supply Outlook for 2026: Expert Perspectives on Clinical Trial Supply Chain Priorities
Blog post by Clinical Supply Consulting experts
The Sponsor’s Role in UAT for IRT: What Regulators Expect in 2026
Blog post by Krisanne Flynn, Senior Manager, UAT Services
Clinical Trial Supply Planning for the Holiday Season
Blog post by Brandon A. MIller, Associate Director, Lead Consultant
Why Third-Party Script Writing is Critical for IRT UAT Success
Blog post by Krisanne Flynn, Senior Manager, UAT Services
Drug Expiry Date Extension Case Study: Ensuring Treatment Continuity
Blog post by George Cortez, Director, Principal Consultant
Audit-Ready UAT: A Sponsor’s Guide to Global Compliance
Blog post by Krisanne Flynn, Senior Manager, UAT Services
Building Clinical Supply Confidence with UAT
Blog post by George Cortez, Director, Clinical Supplies
How Rigorous Clinical Trial UAT Prevents Supply Risk
Blog post by George Cortez, Director, Clinical Supplies
Clinical Supply Chain Case Study
Blog post by Brandon A. Miller, Associate Director, Clinical Supplies